Bioqual
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Bioqual generated cash of $9,359,072, which is more than the previous year. Cash used in financing activities reached the amount of -$447,208 last year. Net change in cash is therefore $8,314,734.
Cash Flow
| 2016 | 2.51M | -446.65K | -602.33K |
|---|---|---|---|
| 2018 | 3.70M | -1.98M | -853.26K |
| 2020 | 4.07M | -2.40M | -626.09K |
| 2021 | 2.14M | -3.69M | -983.85K |
| 2023 | 8.23M | -2.24M | -894.41K |
| 2024 | 9.35M | -597.13K | -447.20K |
BIOQ Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 7.27M | 2.18M | 10.25M | 9.20M | 9.28M | 3.70M |
Operating activities | ||||||
Net income | 483.48K | 835.54K | 6.32M | 4.23M | 3.66M | 2.87M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 2.55M | 5.83M | 4.45M | 4.27M | 741.51K | 692.14K |
Stock-based compensation expense | 0 | 0 | 4.77K | 13.16K | 8.39K | 0 |
| Deferred income tax benefit | 0 | 0 | 4.77K | 13.16K | 8.39K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 6.79M | 6.12M | -5.47M | -3.10M | -988.99K | -1.45M |
Inventories | 0 | 0 | 0 | 0 | -491.61K | 0 |
Accounts payable | -214.45K | -1.69M | -368.37K | 1.16M | 562.62K | 415.07K |
Cash generated by operating activities | 9.35M | 8.23M | 2.14M | 4.07M | 3.70M | 2.51M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -597.13K | -2.24M | -4.40M | -2.40M | -2.07M | -482.85K |
Acquisitions Net | 0 | 2K | 0 | 0 | 16K | 36.2K |
Cash generated by investing activities | -597.13K | -2.24M | -3.69M | -2.40M | -1.98M | -446.65K |
Financing activities | ||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | -447.20K | -894.41K | -983.85K | -626.09K | -536.05K | -312.71K |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | -838 |
Repayments of term debt | 0 | 0 | 0 | 0 | -317.21K | -288.77K |
Cash used in financing activities | -447.20K | -894.41K | -983.85K | -626.09K | -853.26K | -602.33K |
Net Change In Cash | 8.31M | 5.09M | -2.53M | 1.04M | 872.16K | 1.46M |
Cash at end of period | 15.59M | 7.27M | 7.71M | 10.25M | 10.16M | 5.17M |